OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0938-AT82 View EO 12866 Meetings | Received Date: 12/27/2019 |
| Title: Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value Based Payments (VBP) for Drugs Covered in Medicaid (CMS-2482-P) | |
| Agency/Subagency: HHS / CMS | Stage: Proposed Rule |
| Concluded Action: Consistent with Change | Concluded Date: 06/09/2020 |
| Legal Deadline: None | Economically Significant: No |
| Publication Date: 06/19/2020 | Unfunded Mandates: No |
| Major: No | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: No | Small Entities Affected: |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: No | |
An official website of the United States government



